Search research articles
Contact Us
Filters
Showing results (51-60 of 224) with videos related to
Page
of 23
Sort By:
British Journal of Haematology
|
June 3, 2015
Controversial fluorescence in situ hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohort
Matthew S Davids, Alexander Vartanov, Lillian Werner, et al.
Annals of Hematology
|
September 12, 2024
Treatment patterns and burden of infection in patients with chronic lymphocytic leukemia and secondary immunodeficiency: a retrospective database study
Csaba Siffel, Joshua Richter, Colin Anderson-Smits, et al.
Blood
|
March 2, 2018
Risk of hepatitis B virus reactivation in patients treated with ibrutinib
Sarah P Hammond, Kaiwen Chen, Alisha Pandit, et al.
Clinical Therapeutics
|
October 9, 2020
Comparative Efficacy of Acalabrutinib in Frontline Treatment of Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-analysis
Matthew S Davids, Catherine Waweru, Pauline Le Nouveau, et al.
Blood Advances
|
July 10, 2023
Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia
Salma Parvin, Aditi Aryal, Shanye Yin, et al.
Critical Reviews in Oncology/Hematology
|
December 31, 2020
Clinical efficacy and safety of first-line treatments in patients with mantle cell lymphoma: A systematic literature review
Neerav Monga, Constantine Tam, Jamie Garside, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
BTK Inhibitors in Cancer Patients with COVID-19: "The Winner Will be the One Who Controls That Chaos" (Napoleon Bonaparte)
Elise A Chong, Lindsey E Roeker, Mazyar Shadman, et al.
JAMA Dermatology
|
January 17, 2014
Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia
Nicole F Velez, Pritesh S Karia, Alexander R Vartanov, et al.
Redox Biology
|
June 20, 2021
The redox-senescence axis and its therapeutic targeting
Natalie Yl Ngoi, Angeline Qx Liew, Stephen J F Chong, et al.
Leukemia & Lymphoma
|
July 25, 2018
Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib
Kaelyn C Cummins, Matthew P Cheng, David W Kubiak, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 224) with videos related to
Sort By:
Page
of 23
British Journal of Haematology
|
June 3, 2015
Controversial fluorescence in situ hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohort
Matthew S Davids, Alexander Vartanov, Lillian Werner, et al.
Annals of Hematology
|
September 12, 2024
Treatment patterns and burden of infection in patients with chronic lymphocytic leukemia and secondary immunodeficiency: a retrospective database study
Csaba Siffel, Joshua Richter, Colin Anderson-Smits, et al.
Blood
|
March 2, 2018
Risk of hepatitis B virus reactivation in patients treated with ibrutinib
Sarah P Hammond, Kaiwen Chen, Alisha Pandit, et al.
Clinical Therapeutics
|
October 9, 2020
Comparative Efficacy of Acalabrutinib in Frontline Treatment of Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-analysis
Matthew S Davids, Catherine Waweru, Pauline Le Nouveau, et al.
Blood Advances
|
July 10, 2023
Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia
Salma Parvin, Aditi Aryal, Shanye Yin, et al.
Critical Reviews in Oncology/Hematology
|
December 31, 2020
Clinical efficacy and safety of first-line treatments in patients with mantle cell lymphoma: A systematic literature review
Neerav Monga, Constantine Tam, Jamie Garside, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
BTK Inhibitors in Cancer Patients with COVID-19: "The Winner Will be the One Who Controls That Chaos" (Napoleon Bonaparte)
Elise A Chong, Lindsey E Roeker, Mazyar Shadman, et al.
JAMA Dermatology
|
January 17, 2014
Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia
Nicole F Velez, Pritesh S Karia, Alexander R Vartanov, et al.
Redox Biology
|
June 20, 2021
The redox-senescence axis and its therapeutic targeting
Natalie Yl Ngoi, Angeline Qx Liew, Stephen J F Chong, et al.
Leukemia & Lymphoma
|
July 25, 2018
Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib
Kaelyn C Cummins, Matthew P Cheng, David W Kubiak, et al.
Page
of 23